| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.044 | 0.4 |